Watson Pharmaceuticals Inc. (WPI) has agreed to acquire privately held drug maker Arrow Group in a $1.75 billion cash and stock deal, which will expand Watson's global reach and give it exclusive initial U.S. rights for the generic version of the cholesterol-lowering drug Lipitor.

Cegedim, the world leader in CRM (Customer Relationship Management) solutions for the pharmaceutical industry, announces the acquisition from Bisnode of the Nomi Group, one of the first solution providers for business intelligence and sales effectiveness dedicated to the pharmaceutical industry in the Nordic region.

FMCG major Dabur is stepping up expansion in the skin care segment, on the back of its acquisition of Fem Care Pharma last year; with plans to expand range of products from the latter's stable besides launching a new brand of its own.

The Pharmaceutical Exports Promotion Council (Pharmexcil) will soon appoint an expert advisory cell under its aegis to support the pharma small and medium entrepreneurs (SMEs) entering into new overseas markets.